Singapore markets closed
Straits Times Index
3,111.65 +18.85 (+0.61%) Nikkei
26,491.97 +320.72 (+1.23%) Hang Seng
21,719.06 +445.19 (+2.09%) FTSE 100
7,208.81 +188.36 (+2.68%) BTC-USD
21,436.22 +237.56 (+1.12%) CMC Crypto 200
462.12 +8.22 (+1.81%)
CHRS Aug 2022 25.000 put
OPR - OPR Delayed Price. Currency in USD
Add to watchlist
As of 10:44AM EDT. Market open.
| Previous close | 8.20 |
| Open | 8.20 |
| Bid | 0.00 |
| Ask | 0.00 |
| Strike | 25.00 |
| Expiry date | 2022-08-19 |
| Day's range | 8.20 - 8.20 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
- Motley Fool
Coherus BioSciences (CHRS) Q1 2022 Earnings Call Transcript
Today's call includes forward-looking statements regarding Coherus' current expectations about future events. All these future events involve substantial risks and uncertainties that are beyond our control and could cause actual results, performance, or achievements to differ from the results, performance, or achievements implied by the forward-looking statements.
- Zacks
Coherus BioSciences (CHRS) Reports Q1 Loss, Misses Revenue Estimates
Coherus BioSciences (CHRS) delivered earnings and revenue surprises of -55% and 11.68%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
- Zacks
Coherus BioSciences (CHRS) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
Coherus BioSciences (CHRS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
© 2022 Yahoo. All rights reserved.
